Cargando…

Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council

BACKGROUND: Atopic dermatitis (AD) is a chronic, inflammatory skin disease that affects as many as 12.5% of children aged 0-17 years and 3% of the adult population. In the United States, 31.6 million children and adults are estimated to be living with AD. OBJECTIVE: Therapeutic patient education (TP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichenfield, Lawrence F., Kusari, Ayan, Han, Allison M., Barbarot, Sébastien, Deleuran, Mette, Lio, Peter, Marcoux, Danielle, Nosbaum, Audrey, Stalder, Jean-Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361897/ https://www.ncbi.nlm.nih.gov/pubmed/34409365 http://dx.doi.org/10.1016/j.jdin.2021.01.001

Ejemplares similares

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey
por: Drucker, Aaron M., et al.
Publicado: (2022)

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018)

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries
por: Vermeulen, F.M., et al.
Publicado: (2019)

Recent advances in understanding and preventing peanut and tree nut hypersensitivity
por: Kusari, Ayan, et al.
Publicado: (2018)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study
por: Su, John C., et al.
Publicado: (2021)

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
por: Alexander, H., et al.
Publicado: (2019)

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries
por: Gerbens, Louise A. A., et al.
Publicado: (2017)

TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries
por: Gerbens, L.A.A., et al.
Publicado: (2018)

Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
por: Eyerich, Kilian, et al.
Publicado: (2018)

What’s New in Topicals for Atopic Dermatitis?
por: Kleinman, Elana, et al.
Publicado: (2022)

Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020)

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)
por: Chalmers, JR, et al.
Publicado: (2014)

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019)

Eczema herpeticum: A medical emergency in patients with atopic dermatitis
por: Vera-Kellet, Cristián, et al.
Publicado: (2019)

Nomenclature and clinical phenotypes of atopic dermatitis
por: Girolomoni, Giampiero, et al.
Publicado: (2021)

TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents
por: Moret, Leïla, et al.
Publicado: (2013)

Alternative, Complementary, and Forgotten Remedies for Atopic Dermatitis
por: Goddard, Allison L., et al.
Publicado: (2015)

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the “con” view
por: Ginsberg, David N., et al.
Publicado: (2016)

Difficult to control atopic dermatitis
por: Darsow, Ulf, et al.
Publicado: (2013)

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
por: Eichenfield, Lawrence F., et al.
Publicado: (2019)

PATCH TESTING WITH DERMATOPHAGOIDES AND ITS CORRELATION WITH CHRONIC ECZEMA AND ATOPIC DERMATITIS
por: Kapur, Chetna, et al.
Publicado: (2009)

Diet and eczema: a review of dietary supplements for the treatment of atopic dermatitis
por: Schlichte, Megan J., et al.
Publicado: (2016)

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
por: Oosterhaven, Jart A.F., et al.
Publicado: (2019)

Concurrence of Acrodermatitis Enteropathica and Eczema Herpeticum in a Child with Atopic Dermatitis
por: Satria, Budi, et al.
Publicado: (2019)

Eczema monkeypoxicum: Report of monkeypox transmission in a patient with atopic dermatitis
por: Xia, Joyce, et al.
Publicado: (2022)

The hen and the egg question in atopic dermatitis: allergy or eczema comes first
por: Allenova, Anastasiia, et al.
Publicado: (2023)

Atopic Eczema
por: Wright, Stephen
Publicado: (1991)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
por: WOLLENBERG, Andreas, et al.
Publicado: (2022)

Association Between Atopic Dermatitis and Educational Attainment in Denmark
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2021)

Eczema and Dermatitis
por: Burgess, Norman
Publicado: (1935)

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial
por: Eichenfield, Lawrence F., et al.
Publicado: (2021)

The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
por: ELSNER, Julie Sophie Hohwü, et al.
Publicado: (2020)

Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults
por: Barrett, Amy, et al.
Publicado: (2019)

Role of human milk oligosaccharide metabolizing bacteria in the development of atopic dermatitis/eczema
por: Rahman, Trisha, et al.
Publicado: (2023)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results
por: Nygaard, Uffe, et al.
Publicado: (2016)

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema
por: Vermeulen, F.M., et al.
Publicado: (2020)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
por: DELEURAN, Mette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mln8ggfhnlchdc4ckqfli35sfg